About this site.

What this project is

Buy Wolverine is an independent editorial project that publishes summaries of the peer-reviewed research literature on the BPC-157 + TB-500 peptide blend — a pairing that research-peptide forums and online communities sometimes refer to under the informal nickname Wolverine. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The articles on this site are written from the published research — peer-reviewed journal articles, FDA and WADA regulatory records, ClinicalTrials.gov registrations, and reputable systematic and narrative reviews. We cite our sources inline and collect them on the references page. Where a question is not settled in the literature, we say so. Where a finding rests on a single laboratory or a small, uncontrolled study, we flag that too.

Why the domain is called what it is

The domain name begins with the word buy. We want to be unambiguous about what that does and does not signal.

The word buy in the domain reflects search-query patterns — what people type when they are looking for information about a compound — rather than what we offer. Nothing on this site is for sale. We do not stock, ship, broker, or refer out either BPC-157 or TB-500. We are not affiliated with any vendor that does. The compounds we summarize are FDA Category 2 substances under section 503A, prohibiting their use in pharmacy compounding for human use, and they are on the WADA Prohibited List for athletes (BPC-157 under S0, TB-500 / thymosin beta-4 under S2). Neither is approved by the FDA, EMA, MHRA, TGA, or any other major regulator for any human indication.

The second word, Wolverine, is research-community shorthand for the rapid-healing phenotype that some forum users associate with the BPC-157 + TB-500 pairing. It is not a brand we own, not a trademark we have any license to use, and not a reference to any character or franchise. We use it once on the home page to acknowledge the search term that probably brought you here, and otherwise we refer to the compound as the BPC-157 + TB-500 research blend.

Editorial standards

Every quantitative claim on this site cites a specific published study. Where we report a dose, a half-life, a percentage, or a trial result, the underlying source is linked on the references page and can be checked directly against PubMed, PubMed Central, or the relevant journal record.

We try to write in plain language without losing the technical precision that the research demands. When we use a technical term — angiogenesis, G-actin sequestration, integrin-linked kinase, Phase II completers — we define it on first use. Our reading of the literature is not the only possible reading, but it is a careful one and the sources are all there for the reader to evaluate independently.

We do not run advertising. We do not accept sponsored placements. We do not run an affiliate program. We do not collect newsletter signups. The site is, by design, the least commercially active page you can build on a domain that starts with the word buy.

What this site is not

This is not medical advice. It is not a buying guide. It is not a vendor directory. It is not a protocol or a dosing schedule. It is not a referral service. It is not a discussion forum or a community.

The domain modifier buy in the name is editorial framing — a position the publisher occupies relative to the literature, not a claim about the site's services. Readers seeking medical advice should consult a qualified healthcare professional. Readers seeking to purchase research peptides should evaluate their own jurisdiction's regulations and the regulatory status of each compound. Readers seeking to compete in WADA-governed sport should not use either BPC-157 or TB-500.